Abstract

This paper presents a comprehensive predictive model designed to assess the financial impact of personalized medicine, focusing on minimizing healthcare costs while maximizing treatment efficacy. Personalized medicine has emerged as a transformative approach in modern healthcare, offering tailored therapies that align with individual patient characteristics. However, despite its potential benefits, the economic implications of these treatments remain inadequately understood. This study employs a quantitative research design, integrating diverse data sources through surveys, interviews, and electronic health records, to evaluate the cost-effectiveness of personalized therapies. The model incorporates key variables, including patient demographics, treatment pathways, and economic factors, enabling a nuanced analysis of treatment outcomes and costs. The findings indicate that personalized medicine enhances clinical effectiveness and offers significant cost-saving opportunities within healthcare systems. A comparison of this predictive model with existing frameworks highlights its unique capacity to provide a holistic assessment of the financial implications of personalized therapies. The study concludes with recommendations for healthcare providers and policymakers, emphasizing the need for integrating personalized medicine into clinical practice and developing supportive health policies. By prioritizing personalized approaches and fostering stakeholder collaboration, the healthcare community can optimize patient outcomes and promote sustainable healthcare delivery.